Herbert Müller-Hartmann

Herbert Mueller-Hartmann is an accomplished biotechnology and biopharma leader with extensive experience in research and development, project management, and operational strategy. Currently serving as CEO and Co-Founder of Ningaloo Biosystems GmbH, Mueller-Hartmann has previously held key positions including Chief Technology Officer and Head of Operations/Research and Development at Cellbox Solutions. With a strong background in bioprocessing technologies and cell and gene therapy, Mueller-Hartmann has led R&D initiatives at Lonza, where roles included Head of Biosolutions R&D, Head of Global Research & Technology, and Head of Research and Technology. Additionally, Mueller-Hartmann has contributed to education through lectureships in genetics and vocational training in molecular and cellular biology, complementing a PhD in Molecular Genetics from the University of Cologne.